AP NEWS

CLASS ACTION UPDATE for IMMU, AGN, MAXR and MU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

February 11, 2019

NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Immunomedics, Inc. (NASDAQ: IMMU) Class Period: February 8, 2018 - January 18, 2019 Lead Plaintiff Deadline: February 25, 2019 Join the action: https://www.zlk.com/pslra-1/immunomedics-inc-loss-form?wire=3

The lawsuit alleges: Immunomedics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Immunomedics’ Morris Plains, New Jersey drug substance manufacturing facility was not in compliance with FDA requirements; (ii) the Company’s Quality Control Unit did not possess the authority to investigate and correct critical FDA violations occurring at the Morris Plains, New Jersey facility; (iii) the Company suffered a February 2018 data integrity breach at the Morris Plains, New Jersey facility which, among other issues, included the backdating records and manipulation of bioburden samples; (iv) the Company’s Chemistry, Manufacturing and Control data submitted in connection with its BLA for sacituzumab govitecan was insufficient to support FDA approval; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times

To learn more about the Immunomedics, Inc. class action contact jlevi@levikorsinsky.com.

Allergan plc (NYSE: AGN) Class Period: February 24, 2017 - December 19, 2018 Lead Plaintiff Deadline: February 19, 2019 Join the action: https://www.zlk.com/pslra-1/allergan-plc-loss-form?wire=3

The lawsuit alleges: Allergan plc made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) textured breast implants manufactured by Allergan were linked to ALCL; (ii) the foregoing link to cancer, when revealed, would foreseeably force Allergan to recall those textured breast implants from the market; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To learn more about the Allergan plc class action contact jlevi@levikorsinsky.com.

Maxar Technologies Inc. (NYSE: MAXR) Class Period: March 29, 2018 - January 7, 2019 Lead Plaintiff Deadline: March 15, 2019 Join the action: https://www.zlk.com/pslra-1/maxar-technologies-inc-loss-form?wire=3

The lawsuit alleges: Maxar Technologies Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Maxar improperly inflated the value of its intangible assets, among other accounting improprieties; (ii) Maxar’s highly-valued WorldView-4 was equipped with CMGs that were faulty and/or ill-suited for their designed and intended purpose; and (iii) as a result, Maxar’s public statements were materially false and misleading at all relevant times.

To learn more about the Maxar Technologies Inc. class action contact jlevi@levikorsinsky.com.

Micron Technology Inc. (NASDAQGS: MU) Class Period: September 26, 2017 - November 19, 2018 Lead Plaintiff Deadline: March 25, 2019 Join the action: https://www.zlk.com/pslra-1/micron-technology-inc-loss-form?wire=3

The lawsuit alleges that, during the class period, Micron Technology Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company engaged in anti-competitive behavior, including artificially restricting supply growth of DRAM; (2) these anti-competitive efforts were reasonably likely to lead to regulatory scrutiny; (3) the Company’s anti-competitive efforts artificially boosted its operating metrics; (4) as a result, the Company’s financial performance, including revenue, was overstated; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more about the Micron Technology Inc. class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.55 Broadway, 10th FloorNew York, NY 10006 jlevi@levikorsinsky.com Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (212) 363-7171 www.zlk.com

AP RADIO
Update hourly